ID

43670

Descrizione

Plasma Modifications Associated With Rivaroxaban® Treatment for Stroke Prevention; ODM derived from: https://clinicaltrials.gov/show/NCT02273700

collegamento

https://clinicaltrials.gov/show/NCT02273700

Keywords

versioni (2)
  1. 25/04/16 25/04/16 -
  2. 20/09/21 20/09/21 -
Caricato su

20 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Atrial Fibrillation NCT02273700

Inglese

Eligibility Atrial Fibrillation NCT02273700

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient was correctly informed about the study, its implementation, objectives, associated restrictions and patient rights
Descrizione

Informing patient Study

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0588446
UMLS CUI [1,2]
C2603343
the patient must have given his/her informed and signed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
the patient must be insured or beneficiary of a health insurance plan
Descrizione

health insurance plan

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679933
the patient is available for 1 month of follow-up
Descrizione

Availability Follow-up

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1522577
the patient has non-valvular atrial fibrillation that was diagnosed within the last 3 months. documentation of atrial fibrillation by a 12-lead ecg, an ecg rhythm strip, atrial fibrillation episode lasting at least 30 seconds.
Descrizione

Atrial Fibrillation | 12 lead ECG | electrocardiogram rhythm strip | Episode of Atrial Fibrillation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0430456
UMLS CUI [3]
C2022160
UMLS CUI [4,1]
C0332189
UMLS CUI [4,2]
C0004238
the patient has a cha2-ds2-vasc score = 1, that is to say the presence of at least one of the following risk factors: (1) congestive heart failure or moderate to severe systolic dysfunction of the left ventricle; (2) history of systolic blood pressure> 160 mmhg; (3) diabetes; (4) history of ischemic stroke or systemic embolism; (5) vascular disease (myocardial infarction, arterial disease); (6) age > 65 years; (7) female.
Descrizione

Cerebrovascular accident Score | Congestive heart failure | Moderate left ventricular systolic dysfunction | Severe left ventricular systolic dysfunction | Systolic Pressure | Diabetes Mellitus | Ischemic stroke | EMBOLISM, SYSTEMIC ARTERIAL | Vascular Diseases | Myocardial Infarction | Arteriopathic disease | Age | Female

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0449820
UMLS CUI [2]
C0018802
UMLS CUI [3]
C3266752
UMLS CUI [4]
C3266753
UMLS CUI [5]
C0871470
UMLS CUI [6]
C0011849
UMLS CUI [7]
C0948008
UMLS CUI [8]
C0149876
UMLS CUI [9]
C0042373
UMLS CUI [10]
C0027051
UMLS CUI [11]
C0852949
UMLS CUI [12]
C0001779
UMLS CUI [13]
C0086287
the patient will start rivaroxaban (xarelto®) at the nîmes university hospital
Descrizione

rivaroxaban Xarelto | Hospitals, University

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1739768
UMLS CUI [1,2]
C3159309
UMLS CUI [2]
C0020028
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient is participating in another interventional study
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
the patient has participated in another interventional study within the past three months
Descrizione

Study Subject Participation Status Past

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1444637
the patient is in an exclusion period determined by a previous study
Descrizione

Exclusion Criteria Period

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1948053
the patient is under judicial protection, under tutorship or curatorship
Descrizione

judicial aspects

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0243116
the patient refuses to sign the consent
Descrizione

Unwilling Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0558080
UMLS CUI [1,2]
C0021430
it is impossible to correctly inform the patient
Descrizione

Informing patient Unsuccessful

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0588446
UMLS CUI [1,2]
C1272705
the patient is pregnant, parturient, or breastfeeding
Descrizione

Pregnancy | Parturition | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0005615
UMLS CUI [3]
C0006147
presence of a mechanical heart valve or valve disease
Descrizione

HEART-VALVE, MECHANICAL | Heart valve disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0493527
UMLS CUI [2]
C0018824
patient who recieved another new direct oral anticoagulant other than xarelto® in the previous three months
Descrizione

Other oral anticoagulants

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0354604
UMLS CUI [1,2]
C0205394
Ritorna all'inizio della pagina

Similar models

Eligibility Atrial Fibrillation NCT02273700

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informing patient Study
Item
the patient was correctly informed about the study, its implementation, objectives, associated restrictions and patient rights
boolean
C0588446 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
Informed Consent
Item
the patient must have given his/her informed and signed consent
boolean
C0021430 (UMLS CUI [1])
health insurance plan
Item
the patient must be insured or beneficiary of a health insurance plan
boolean
C0679933 (UMLS CUI [1])
Availability Follow-up
Item
the patient is available for 1 month of follow-up
boolean
C0470187 (UMLS CUI [1,1])
C1522577 (UMLS CUI [1,2])
Atrial Fibrillation | 12 lead ECG | electrocardiogram rhythm strip | Episode of Atrial Fibrillation
Item
the patient has non-valvular atrial fibrillation that was diagnosed within the last 3 months. documentation of atrial fibrillation by a 12-lead ecg, an ecg rhythm strip, atrial fibrillation episode lasting at least 30 seconds.
boolean
C0004238 (UMLS CUI [1])
C0430456 (UMLS CUI [2])
C2022160 (UMLS CUI [3])
C0332189 (UMLS CUI [4,1])
C0004238 (UMLS CUI [4,2])
Cerebrovascular accident Score | Congestive heart failure | Moderate left ventricular systolic dysfunction | Severe left ventricular systolic dysfunction | Systolic Pressure | Diabetes Mellitus | Ischemic stroke | EMBOLISM, SYSTEMIC ARTERIAL | Vascular Diseases | Myocardial Infarction | Arteriopathic disease | Age | Female
Item
the patient has a cha2-ds2-vasc score = 1, that is to say the presence of at least one of the following risk factors: (1) congestive heart failure or moderate to severe systolic dysfunction of the left ventricle; (2) history of systolic blood pressure> 160 mmhg; (3) diabetes; (4) history of ischemic stroke or systemic embolism; (5) vascular disease (myocardial infarction, arterial disease); (6) age > 65 years; (7) female.
boolean
C0038454 (UMLS CUI [1,1])
C0449820 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2])
C3266752 (UMLS CUI [3])
C3266753 (UMLS CUI [4])
C0871470 (UMLS CUI [5])
C0011849 (UMLS CUI [6])
C0948008 (UMLS CUI [7])
C0149876 (UMLS CUI [8])
C0042373 (UMLS CUI [9])
C0027051 (UMLS CUI [10])
C0852949 (UMLS CUI [11])
C0001779 (UMLS CUI [12])
C0086287 (UMLS CUI [13])
rivaroxaban Xarelto | Hospitals, University
Item
the patient will start rivaroxaban (xarelto®) at the nîmes university hospital
boolean
C1739768 (UMLS CUI [1,1])
C3159309 (UMLS CUI [1,2])
C0020028 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
the patient is participating in another interventional study
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status Past
Item
the patient has participated in another interventional study within the past three months
boolean
C2348568 (UMLS CUI [1,1])
C1444637 (UMLS CUI [1,2])
Exclusion Criteria Period
Item
the patient is in an exclusion period determined by a previous study
boolean
C0680251 (UMLS CUI [1,1])
C1948053 (UMLS CUI [1,2])
judicial aspects
Item
the patient is under judicial protection, under tutorship or curatorship
boolean
C0243116 (UMLS CUI [1])
Unwilling Informed Consent
Item
the patient refuses to sign the consent
boolean
C0558080 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Informing patient Unsuccessful
Item
it is impossible to correctly inform the patient
boolean
C0588446 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
Pregnancy | Parturition | Breast Feeding
Item
the patient is pregnant, parturient, or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0005615 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
HEART-VALVE, MECHANICAL | Heart valve disease
Item
presence of a mechanical heart valve or valve disease
boolean
C0493527 (UMLS CUI [1])
C0018824 (UMLS CUI [2])
Other oral anticoagulants
Item
patient who recieved another new direct oral anticoagulant other than xarelto® in the previous three months
boolean
C0354604 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial